http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
관상동맥 중재술을 받은 급성 심근경색증 환자의 저밀도 지단백 콜레스테롤 수치와 임상경과
조경훈 ( Kyung Hoon Cho ),정명호 ( Myung Ho Jeong ),박근호 ( Keun Ho Park ),이민구 ( Min Goo Lee ),고점석 ( Jum Suk Ko ),이신은 ( Shin Eun Lee ),강원유 ( Won Yu Kang ),김수현 ( Soo Hyun Kim ),심두선 ( Doo Sun Sim ),윤남식 ( Nam Si 대한내과학회 2009 대한내과학회지 Vol.76 No.6
Background/Aims: This study examined the relationship between the low-density lipoprotein cholesterol (LDL-C) level and clinical outcome after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). Methods: Between January 2006 and December 2007, 867 patients (age, 62.6±12.5 years; males, 71%) undergoing a 1-year follow-up after PCI for AMI were divided into five groups according to the LDL-C level: <70, 70-100, 100-130, 130-160, and ≥160 mg/dL. Results: Smoking (63%), hypertension (46%), and diabetes mellitus (28%) were common risk factors. The history of ischemic heart disease decreased as the LDL-C level increased (p=0.036). Patients with lower LDL-C levels had lower creatinine clearance and higher high-sensitivity C-reactive protein (hsCRP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels. The rate of in-hospital complications after PCI declined with increases in the LDL-C level, except in patients with LDL-C >160 mg/dL (linear p=0.010). There was no correlation between the LDL-C level and the 30-day or 1-year clinical outcome after PCI. After multivariate adjustment, independent predictors of the 1-year mortality after PCI were left ventricular ejection fraction, hsCRP, age, and creatinine clearance. Conclusions: Higher LDL-C levels were related to fewer in-hospital complications, but there was no correlation between the LDL-C level and long-term clinical outcome after PCI in Korean patients with AMI. (Korean J Med 76:692-700, 2009)
심방세동 환자에서 주요 항부정맥제의 전기생리 작용의 차이
장수영 ( Su Young Jang ),조정관 ( Jeong Gwan Cho ),정형기 ( Hyung Ki Jung ),기원주 ( Won Ju Ki ),이경진 ( Kyoung Jin Lee ),고점석 ( Jum Suk Ko ),이민구 ( Min Goo Lee ),박근호 ( Keun Ho Park ),심두선 ( Doo Sun Sim ),윤남식 ( Nam Si 대한내과학회 2011 대한내과학회지 Vol.80 No.6
Background/Aims: Drug-eluting stents (DES) are superior to bare metal stents (BMS) in reducing restenosis rates across a wide range of patients and lesion subsets.This study compared the clinical outcomes of DES versus BMS in patients with large coronary Methods: The study compared 134 patients (59.9±10.6 years, 90 men, 44 women) who underwent single vessel angioplasty with DESimplantation in large vessels with 115 patients (60.3±8.9 years, 82 men, 33 women) who received BMS. The clinical outcomes at 12 months were compared between groups. The study end points were major adverse cardiac events (MACE), including cardiac death, nonfatal myocardial infarction, and the need for target vessel and target lesion revascularization. Results: The baseline clinical coronary angiography and procedural characteristics were similar in both groups. The duration of dual antiplatelet therapy was longer in the DES group than in the BMS group (240±2.7 vs. 348±1.7 days, p=0.042). During the 12-month clinical follow-up, MACE were observed in 13 patients (11.3%) with BMS and 12 patients (9.0%) with DES (p=0.486). Conclusions: For coronary stents implanted in large coronary arteries, DES seems to be more favorable, although no significant differences were observed in the clinical outcomes between DES and BMS during a 1-year clinical follow-up. (Korean J Med2011;80:664-671)